Streetbeat News

Regulatory

MNKD

MannKind Corporation announced it will proceed with a Phase 1 study of Nintedanib DPI (MNKD-201) for treating pulmonary fibrotic diseases. This marks a significant step in the development of treatments for these conditions.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:07 am

VGK

The preliminary Eurozone Consumer Price Index (CPI) for April increased by 0.6%, which is lower than the previous month's increase of 0.8%.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 9:38 am

VGK

The Eurozone Core Consumer Price Index (CPI) for April showed a year-over-year increase of 2.7%, slightly above the estimated 2.6% but below the previous month's 2.9%.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 9:37 am

CYCC

Cyclacel Pharmaceuticals has officially withdrawn its registration statement on Form S-1 with the SEC, as indicated by the filing of Form RW on Monday. This move suggests a change in the company's plans regarding its previously intended public offering or capital raising activities.

Portfolio Pulse from Charles Gross

April 30, 2024 | 9:35 am

TSLA

Tesla Inc (NASDAQ:TSLA) faces a challenge in Q2 with expected lower demand for the Model 3 due to the federal EV tax credit eligibility, favoring the Model Y. The tax credit makes the Model Y cheaper than the Model 3 for eligible customers, potentially impacting Tesla's deliveries. Tesla's first-quarter deliveries declined by 8.5% year-on-year, marking the first drop in quarterly deliveries in four years. Despite this, CEO Elon Musk anticipates higher sales in 2024 compared to 2023.

Portfolio Pulse from Anan Ashraf

April 30, 2024 | 8:40 am

MESO

Mesoblast is planning to resubmit its Biologics License Application (BLA) aiming for an accelerated FDA approval following positive interactions during Q3. This move could significantly impact the company's future, signaling potential growth and advancements in its pipeline.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:14 am

TSLA

Elon Musk's recent visit to China has been highlighted as a significant move for Tesla, showcasing Musk's seriousness and gaining investor confidence. The visit, which included a meeting with China's Li Qiang, signals strong government endorsement in China, a crucial market for Tesla. This comes as Tesla recently met China's data security requirements for its vehicles, a step forward for deploying its full self-driving software in China. Tesla's stock spiked over 15% following these developments, indicating a positive market response.

Portfolio Pulse from Benzinga Neuro

April 30, 2024 | 7:42 am

ARBUSD

BTCUSD

ETHUSD

MATICUSD

OPUSD

Bernstein analysts maintain a $150K Bitcoin price target by 2025 despite slow ETF inflows, citing $12 billion in net inflows since spot bitcoin ETFs launch and strong Bitcoin miner performance. They predict positive outcomes for Ethereum ETFs, potentially boosting ETH and Layer-2 tokens like Arbitrum, Optimism, and Polygon. They also highlight the growth potential in crypto niches and project a total crypto market cap of $7.5 trillion in 18-24 months.

Portfolio Pulse from Ivan Crnogatić

April 30, 2024 | 7:19 am

FXI

China's Non-Manufacturing Purchasing Managers Index (PMI) for April was reported at 51.2, lower than the estimated 52.3 and the previous month's 53.0, indicating a slowdown in the non-manufacturing sector.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 4:41 am

META

SNAP

European Commission President Ursula von der Leyen indicated that a TikTok ban in the EU is possible, following the U.S. where President Biden signed a bill potentially banning TikTok unless ByteDance sells it. The EU has already banned TikTok on corporate phones due to security concerns. This comes as TikTok faces investigations under the EU's Digital Services Act. Observers note that a ban could benefit TikTok's competitors, such as Meta Platforms, Inc. (META) and Snap Inc. (SNAP), which have ties to U.S. Congress members.

Portfolio Pulse from Ananya Gairola

April 30, 2024 | 1:39 am